NeuroPace Inc — Director's Dealing 2021

Apr 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-21

Reporting Person: Accelmed Partners II L.P. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-21	Common Stock	P	588235	$17.00	Acquired	588235	Direct

Footnotes

F1: Reflects shares purchased from the underwriters in the Companys initial public offering.